Global Cardiac Biomarkers Testing Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Cardiac Biomarkers Testing Market Overview

• 1.1 Product Overview and Scope of Cardiac Biomarkers Testing
• 1.2 Classification of Cardiac Biomarkers Testing by Types
  • 1.2.1 Global Cardiac Biomarkers Testing Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Cardiac Biomarkers Testing Revenue Market Share by Types in 2018
  • 1.2.3 Myocardial Muscle Creatine Kinase (CK-MB)
  • 1.2.4 Troponins (T and I)
  • 1.2.5 Myoglobin
  • 1.2.6 Brain Natriuretic Peptide (BNPs) or NT-proBNP
  • 1.2.7 Ischemia-modified Albumin (IMA)
  • 1.2.8 Others
• 1.3 Global Cardiac Biomarkers Testing Market by Application
  • 1.3.1 Global Cardiac Biomarkers Testing Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Myocardial Infarction
  • 1.3.3 Congestive Heart Failure
  • 1.3.4 Acute Coronary Syndrome
  • 1.3.5 Atherosclerosis
  • 1.3.6 Others
• 1.4 Global Cardiac Biomarkers Testing Market by Regions
  • 1.4.1 Global Cardiac Biomarkers Testing Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Cardiac Biomarkers Testing Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Cardiac Biomarkers Testing Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Cardiac Biomarkers Testing Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Cardiac Biomarkers Testing Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Cardiac Biomarkers Testing Status and Prospect (2014-2024)
• 1.5 Global Market Size of Cardiac Biomarkers Testing (2014-2024)

2 Company Profiles

• 2.1 Abbott Laboratories
  • 2.1.1 Business Overview
  • 2.1.2 Cardiac Biomarkers Testing Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Abbott Laboratories Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Becton, Dickinson and Company
  • 2.2.1 Business Overview
  • 2.2.2 Cardiac Biomarkers Testing Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Becton, Dickinson and Company Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 BioMerieux
  • 2.3.1 Business Overview
  • 2.3.2 Cardiac Biomarkers Testing Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 BioMerieux Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 Bio-Rad Laboratories, Inc.
  • 2.4.1 Business Overview
  • 2.4.2 Cardiac Biomarkers Testing Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 Bio-Rad Laboratories, Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 Danaher Corporation
  • 2.5.1 Business Overview
  • 2.5.2 Cardiac Biomarkers Testing Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 Danaher Corporation Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 F. HOFFMANN-LA ROCHE LTD.
  • 2.6.1 Business Overview
  • 2.6.2 Cardiac Biomarkers Testing Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 F. HOFFMANN-LA ROCHE LTD. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
• 2.7 Siemens AG
  • 2.7.1 Business Overview
  • 2.7.2 Cardiac Biomarkers Testing Type and Applications
    • 2.7.2.1 Product A
    • 2.7.2.2 Product B
  • 2.7.3 Siemens AG Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
• 2.8 Thermo Fisher Scientific, Inc.
  • 2.8.1 Business Overview
  • 2.8.2 Cardiac Biomarkers Testing Type and Applications
    • 2.8.2.1 Product A
    • 2.8.2.2 Product B
  • 2.8.3 Thermo Fisher Scientific, Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
• 2.9 PerkinElmer Inc.
  • 2.9.1 Business Overview
  • 2.9.2 Cardiac Biomarkers Testing Type and Applications
    • 2.9.2.1 Product A
    • 2.9.2.2 Product B
  • 2.9.3 PerkinElmer Inc. Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)
• 2.10 Tosoh Corporation
  • 2.10.1 Business Overview
  • 2.10.2 Cardiac Biomarkers Testing Type and Applications
    • 2.10.2.1 Product A
    • 2.10.2.2 Product B
  • 2.10.3 Tosoh Corporation Cardiac Biomarkers Testing Revenue, Gross Margin and Market Share (2017-2018)

3 Global Cardiac Biomarkers Testing Market Competition, by Players

• 3.1 Global Cardiac Biomarkers Testing Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Cardiac Biomarkers Testing Players Market Share
  • 3.2.2 Top 10 Cardiac Biomarkers Testing Players Market Share
• 3.3 Market Competition Trend

4 Global Cardiac Biomarkers Testing Market Size by Regions

• 4.1 Global Cardiac Biomarkers Testing Revenue and Market Share by Regions
• 4.2 North America Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
• 4.3 Europe Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
• 4.5 South America Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)

5 North America Cardiac Biomarkers Testing Revenue by Countries

• 5.1 North America Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
• 5.2 USA Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
• 5.3 Canada Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)

6 Europe Cardiac Biomarkers Testing Revenue by Countries

• 6.1 Europe Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
• 6.2 Germany Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
• 6.3 UK Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
• 6.4 France Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
• 6.5 Russia Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
• 6.6 Italy Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Cardiac Biomarkers Testing Revenue by Countries

• 7.1 Asia-Pacific Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
• 7.2 China Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
• 7.3 Japan Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
• 7.4 Korea Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
• 7.5 India Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)

8 South America Cardiac Biomarkers Testing Revenue by Countries

• 8.1 South America Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
• 8.2 Brazil Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Cardiac Biomarkers Testing by Countries

• 9.1 Middle East and Africa Cardiac Biomarkers Testing Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
• 9.3 UAE Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Cardiac Biomarkers Testing Revenue and Growth Rate (2014-2019)

10 Global Cardiac Biomarkers Testing Market Segment by Type

• 10.1 Global Cardiac Biomarkers Testing Revenue and Market Share by Type (2014-2019)
• 10.2 Global Cardiac Biomarkers Testing Market Forecast by Type (2019-2024)
• 10.3 Myocardial Muscle Creatine Kinase (CK-MB) Revenue Growth Rate (2014-2024)
• 10.4 Troponins (T and I) Revenue Growth Rate (2014-2024)
• 10.5 Myoglobin Revenue Growth Rate (2014-2024)
• 10.6 Brain Natriuretic Peptide (BNPs) or NT-proBNP Revenue Growth Rate (2014-2024)
• 10.7 Ischemia-modified Albumin (IMA) Revenue Growth Rate (2014-2024)
• 10.8 Others Revenue Growth Rate (2014-2024)

11 Global Cardiac Biomarkers Testing Market Segment by Application

• 11.1 Global Cardiac Biomarkers Testing Revenue Market Share by Application (2014-2019)
• 11.2 Cardiac Biomarkers Testing Market Forecast by Application (2019-2024)
• 11.3 Myocardial Infarction Revenue Growth (2014-2019)
• 11.4 Congestive Heart Failure Revenue Growth (2014-2019)
• 11.5 Acute Coronary Syndrome Revenue Growth (2014-2019)
• 11.6 Atherosclerosis Revenue Growth (2014-2019)
• 11.7 Others Revenue Growth (2014-2019)

12 Global Cardiac Biomarkers Testing Market Size Forecast (2019-2024)

• 12.1 Global Cardiac Biomarkers Testing Market Size Forecast (2019-2024)
• 12.2 Global Cardiac Biomarkers Testing Market Forecast by Regions (2019-2024)
• 12.3 North America Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
• 12.4 Europe Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
• 12.6 South America Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Cardiac Biomarkers Testing Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology